Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark D Pescovitz

Showing results (1-10 of 63) with videos related to

Pageof 7
Sort By:
Expert Review of Clinical Immunology|May 19, 2010
Daclizumab: humanized monoclonal antibody to the interleukin-2 receptorMark D Pescovitz
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|December 23, 2003
Prevention and treatment of cytomegalovirus disease in solid organ transplant recipients: the clinical and economic impact of evolving strategies. IntroductionMark D Pescovitz
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|December 23, 2003
Formulary considerations for drugs used to prevent cytomegalovirus diseaseMark D Pescovitz
Transplantation|July 22, 2006
Benefits of cytomegalovirus prophylaxis in solid organ transplantationMark D Pescovitz
Saudi Journal of Kidney Diseases and Transplantation : an Official Publication of the Saudi Center for Organ Transplantation, Saudi Arabia|October 24, 2007
Review of the CMV in renal transplantationMark D Pescovitz
Clinical Transplantation|March 25, 2006
B cells: a rational target in alloantibody-mediated solid organ transplantation rejectionMark D Pescovitz
Pediatric Transplantation|March 11, 2004
The use of rituximab, anti-CD20 monoclonal antibody, in pediatric transplantationMark D Pescovitz
Transplantation|July 14, 2007
Is low-dose valganciclovir the same as appropriate-dose valganciclovir?Mark D Pescovitz
Current Opinion in Organ Transplantation|December 9, 2008
Use of antibody induction in pediatric renal transplantationMark D Pescovitz
Seminars in Pediatric Surgery|July 5, 2006
Immunosuppression in pediatric solid organ transplantationAvinash Agarwal, Mark D Pescovitz
Pageof 7

Showing results (1-10 of 63) with videos related to

Sort By:
Pageof 7
Expert Review of Clinical Immunology|May 19, 2010
Daclizumab: humanized monoclonal antibody to the interleukin-2 receptorMark D Pescovitz
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|December 23, 2003
Prevention and treatment of cytomegalovirus disease in solid organ transplant recipients: the clinical and economic impact of evolving strategies. IntroductionMark D Pescovitz
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|December 23, 2003
Formulary considerations for drugs used to prevent cytomegalovirus diseaseMark D Pescovitz
Transplantation|July 22, 2006
Benefits of cytomegalovirus prophylaxis in solid organ transplantationMark D Pescovitz
Saudi Journal of Kidney Diseases and Transplantation : an Official Publication of the Saudi Center for Organ Transplantation, Saudi Arabia|October 24, 2007
Review of the CMV in renal transplantationMark D Pescovitz
Clinical Transplantation|March 25, 2006
B cells: a rational target in alloantibody-mediated solid organ transplantation rejectionMark D Pescovitz
Pediatric Transplantation|March 11, 2004
The use of rituximab, anti-CD20 monoclonal antibody, in pediatric transplantationMark D Pescovitz
Transplantation|July 14, 2007
Is low-dose valganciclovir the same as appropriate-dose valganciclovir?Mark D Pescovitz
Current Opinion in Organ Transplantation|December 9, 2008
Use of antibody induction in pediatric renal transplantationMark D Pescovitz
Seminars in Pediatric Surgery|July 5, 2006
Immunosuppression in pediatric solid organ transplantationAvinash Agarwal, Mark D Pescovitz
Pageof 7